CClinicalTrials.gg
Not yet recruitingNCT07592832Updated May 18, 2026

EFFECTS OF TWO ANESTHESİA TECHNİQUES ON INFLAMMATORY RESPONSE AND AMİNO ACİD METABOLİSM İN THYROİD SURGERY

An interventional study of General Anesthesia and cervical plexus block in General Anesthesia, Cervical Plexus Block and Thyroid Surgery, sponsored by Harran University. Not yet recruiting. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-05-18.

Sponsored by Harran University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

The main aim of this study is to compare the effects of two different anesthesia methods-(1) general anesthesia alone and (2) combination of general anesthesia with cervical plexus block-on postoperative inflammatory process and amino acid metabolism in patients undergoing thyroidectomy.

02

Conditions studied

  • General Anesthesia
  • Cervical Plexus Block
  • Thyroid Surgery
03

In context

Lead sponsor

Harran University is the lead sponsor of 60 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • This includes patients aged 18-70 years
  • classified as ASA I-III
  • who have undergone elective thyroidectomy.

Exclusion criteria

Exclusion Criteria:

  • Patients who did not wish to participate in the study voluntarily
  • patients for whom superficial cervical block was contraindicated
  • pregnant and breastfeeding women
  • patients in ASA IV-V groups were excluded from the study.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    GENERAL ANESTHESIA

    THIS GROUP WILL INCLUDE PATIENTS WHO ARE UNDER GENERAL ANESTHESIA.

    Procedure: cervical plexus block

  • Active comparator
    cervical plexus block

    IN THIS GROUP, CERVICAL PLEXUS BLOCK WILL BE PERFORMED IN ADDITION TO GENERAL ANESTHESIA.

    Procedure: General Anesthesia

Interventions

  • ProcedureGeneral Anesthesia

    In our study, one patient group will receive only general anesthesia, while the other group will receive general anesthesia in addition to ultrasound-guided cervical plexus block. The inflammatory response is a natural response of the body's immune system to surgical trauma, and it can vary depending on the anesthetic agent used. In regulating this response, molecules such as IL-1β, TNF-α, IL-6, IL-10, and IL-40 are important indicators that determine the severity and duration of inflammation. These parameters will be examined and compared in both groups.

  • Procedurecervical plexus block

    In our study, one patient group will receive only general anesthesia, while the other group will receive general anesthesia in addition to ultrasound-guided cervical plexus block.

06

What researchers measure

Primary outcomes

  1. Perioperative Inflammatory Response

    IL-1β, TNF-α, IL-6, IL-10, and IL-40 levels will be measured 1 hour before surgery, and then 2 and 6 hours after surgery, and these values will then be compared.

    Time frame: Before the procedure, and at 2 and 6 hours after the procedure.

  2. Inflammatory Response

    IL-1β, TNF-α, IL-6, IL-10, and IL-40 levels will be measured 1 hour before surgery, and then 2 and 6 hours after surgery, and these values will then be compared.

    Time frame: Before the procedure, and at 2 and 6 hours after the procedure.

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07592832
Lead sponsor
Harran University
Responsible party
ABDULHAKİM ŞENGEL (ANESTHESIA AND RESUSCITATION SPECIALIST, Harran University) — Principal investigator
First posted
May 18, 2026
Start date
Jul 30, 2026 (estimated)
Primary completion
Feb 20, 2027 (estimated)
Completion
Feb 20, 2027 (estimated)
Last update
May 18, 2026

Study contacts

Abdulhakim Şengel
Contact
ahsengel121@gmail.com
+905374030916

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion